Honeywell International Inc. posted quarterly adjusted earnings of $2.25 per share, higher than the year-ago quarter’s $2.02 per share a year ago, and surpassing the Zacks Consensus Estimate of $2.16 per share (as reported in Zacks Equity Research).
Revenues of $8.95 billion, however, missed the Zacks Consensus Estimate by 1.37%. (as reported in Zacks Equity Research). It was $8.47 billion in the year-ago quarter. Organic sales rose +9%.
Honeywell’s Aerospace segment quarterly revenues grew +9% year over year. Building Technologies’ revenues rose +11% year-over-year, while Performance Materials and Technologies’ revenues total revenue increased +8%. Safety and Productivity Solutions revenues fell -7% owing to lower volumes in warehouse and workflow solutions and personal protective equipment.
For full-year 2022, Honeywell re-iterated its free cash flow expectation of $4.70-$5.10 billion. But it revised its forecast of operating cash flow to $5.20-$5.60 billion compared with prior estimate of $5.50-$5.90 billion. It now projects a segment margin of 21.6-21.8% (vs. prior forecast of 21.3-21.7%).
Honeywell now expects sales to be in the range of $35.40-$35.70 billion for 2022, compared with previous guidance of $35.50-$36.10 billion. Organic sales growth expectation is 6-7%, compared with previous projection of 5-7% .
The company now projects 2022 adjusted earnings per share in the range of $8.70-$8.80, boosting its outlook from prior forecast of $8.55-8.80.
HON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 29 cases where HON's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 26, 2025. You may want to consider a long position or call options on HON as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HON advanced for three days, in of 339 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 272 cases where HON Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for HON moved out of overbought territory on May 29, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The Moving Average Convergence Divergence Histogram (MACD) for HON turned negative on June 03, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HON declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows